Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Study of impact of residual clonal PC proliferation rate after ASCT on myeloma outcomes finds S-phase fraction ≥2% is independent predictor of PFS & OS on uni- and multi-variable analyses; dynamic changes also a factor.”
Title: Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma
Authors: Tamer Hellou, Daniel G. Packard, Maximilian J. Steinhardt, Shaji K. Kumar, Angela Dispenzieri, Saurabh Zanwar, Shinichiro Suzuki, Estefania Gauto Mariotti, Dragan Jevremovic, Horatiu Olteanu, Pedro Horna, Gregory Otteson, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Joselle Cook, Nadine Abdallah, Moritz Binder, Rahma Warsame, Taxiarchis V. Kourelis, Ronald S. Go, Yi Lin, Morie A. Gertz.
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
